Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures
15 8월 2018 - 5:11AM
Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company
focused on minimal access surgery, today announced the full
commercial launch of PhotonGuide® Adapt, a novel system that
consists of a flexible illuminator and a family of compatible
retractors for surgical procedures performed vaginally including
pelvic organ prolapse repairs and vaginal hysterectomies.
PhotonGuide Adapt represents a new platform for Invuity. The
flexible nature of the waveguide conforms to different sizes and
shapes of retractors, and allows surgeons to seamlessly adjust the
illumination along the length of the retractor to accommodate the
surgical target. The pairing of the flexible illuminator with a
range of compatible retractors optimizes visualization deep into
the surgical cavity.
“The PhotonGuide Adapt launch marks a major milestone in our
commitment to advancing surgical procedures in women’s health,”
stated Scott Flora, President and CEO of Invuity. “We now have a
comprehensive product portfolio designed to meet the clinical and
economic needs of the surgical gynecologist and their female
patients.”
“I perform over 100 vaginal surgical cases per year, and every
case presents a unique challenge. Invuity’s illumination technology
creates a more efficient surgical experience through its direct
intracavity visualization. This is most beneficial during
Uterosacral Ligament Suspension procedures. During this procedure
with PhotonGuide Adapt, I am not only able to retract the pelvic
organs while protecting the ureters, but I am also able to directly
visualize these organs and other pelvic floor support structures,
which is essential for a great surgical outcome,” explained Doug
Miyazaki, MD, FACOG Novant Health, Winston-Salem, NC.
PhotonGuide Adapt is a significant innovation in vaginal access
instrumentation. Procedures, like pelvic organ prolapse repair and
hysterectomy, require optimal surgical visualization as surgeons
operate deep within the pelvis. PhotonGuide Adapt exemplifies
Invuity’s commitment to enabling surgeons to perform complex
procedures in women’s health with greater confidence, and to give
more women access to transformative options, with the goal of
promoting improved patient satisfaction and quality of life after
surgery.
About Invuity, Inc. (Nasdaq: IVTY):Invuity,
Inc., is a leading medical technology company focused on developing
and marketing advanced surgical devices to improve the surgeon’s
ability to perform minimal access surgery through smaller and
hidden incisions. The Company’s patented Intelligent Photonics®
technology delivers enhanced visualization, which facilitates
surgical precision, efficiency and safety. Clinical applications
include women’s health, encompassing breast cancer and breast
reconstruction surgery, gynecology and thyroid surgery. Additional
applications include procedures for general surgery,
electrophysiology, spine and orthopedics. Invuity is headquartered
in San Francisco, CA. For more information, visit
www.invuity.com
Company contact:Lindsey FujitaInvuity, Inc444 De Haro StreetSan
Francisco, CA 94107415-655-2188
INVUITY, INC. (NASDAQ:IVTY)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
INVUITY, INC. (NASDAQ:IVTY)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025